Inability of kaolin treatment to remove nonspecific inhibitors from equine serum for the hemagglutination inhibition test against equine H7N7 influenza virus

被引:14
作者
Boliar, Salkat
Stanislawek, Wlodek
Chambers, Thomas M. [1 ]
机构
[1] Univ Kentucky, Gluck Equine Res Ctr 108, Dept Vet Sci, Lexington, KY 40546 USA
[2] MAF Biosecur, Invest & Diagnost Ctr Wallaceville, Upper Hutt, New Zealand
关键词
equine influenza virus; HI test; nonspecific inhibitors; serum treatments;
D O I
10.1177/104063870601800305
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The hemagglutination inhibition test is used by many diagnostic and surveillance laboratories for detection of antibodies to influenza viruses. It is well known that the hemagglutination inhibition test is affected by nonspecific inhibitors present in equine serum. Several serum treatments are in use to remove these inhibitors, including treatment with kaolin. Discrepant results were observed in the authors' laboratories when using kaolin treatment before testing equine sera for antibodies against equine influenza virus (EIV) subtype-1 (H7N7). It is demonstrated here that kaolin treatment leads to false positive results when testing for antibodies against EIV subtype-1, as compared to other standard serum treatments (trypsin-periodate, receptor-destroying enzyme). Against EIV subtype-2 (H3N8), however, false positive results were not evident. Trypsin-periodate and receptor-destroying enzyme (RDE) treatments appear to be superior to kaolin for removal of nonspecific inhibitors from equine serum and should be used for serological diagnosis and surveillance of equine influenza virus.
引用
收藏
页码:264 / 267
页数:4
相关论文
共 13 条
[1]   BOVINE AND MOUSE SERUM BETA-INHIBITORS OF INFLUENZA-A VIRUSES ARE MANNOSE-BINDING LECTINS [J].
ANDERS, EM ;
HARTLEY, CA ;
JACKSON, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4485-4489
[2]   ALPHA(2)-MACROGLOBULIN, A MULTIFUNCTIONAL BINDING-PROTEIN WITH TARGETING CHARACTERISTICS [J].
BORTH, W .
FASEB JOURNAL, 1992, 6 (15) :3345-3353
[3]   RECEPTOR SPECIFICITY IN HUMAN, AVIAN, AND EQUINE H2 AND H3 INFLUENZA-VIRUS ISOLATES [J].
CONNOR, RJ ;
KAWAOKA, Y ;
WEBSTER, RG ;
PAULSON, JC .
VIROLOGY, 1994, 205 (01) :17-23
[4]  
FRANCIS T, 1947, J EXP MED, V85, P1, DOI 10.1084/jem.85.1.1
[5]   STANDARDIZED VIRAL HEMAGGLUTINATION AND HEMAGGLUTINATION-INHIBITION TESTS .2. DESCRIPTION AND STATISTICAL EVALUATION [J].
HIERHOLZER, JC ;
SUGGS, MT ;
HALL, EC .
APPLIED MICROBIOLOGY, 1969, 18 (05) :824-+
[6]  
Hsiung G.D., 1973, DIAGNOSTIC VIROLOGY, P26
[7]   INCREASED SENSITIVITY AND REDUCED SPECIFICITY OF HEMAGGLUTINATION INHIBITION TESTS WITH ETHER-TREATED INFLUENZA-B SINGAPORE/222 79 [J].
KENDAL, AP ;
CATE, TR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 18 (04) :930-934
[8]  
MUMFORD JA, 1999, TXB INFLUENZA, P146
[9]  
PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850
[10]   DISTINCT GLYCOPROTEIN INHIBITORS OF INFLUENZA-A VIRUS IN DIFFERENT ANIMAL SERA [J].
RYANPOIRIER, KA ;
KAWAOKA, Y .
JOURNAL OF VIROLOGY, 1991, 65 (01) :389-395